
The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

